Intellectual Property India Publishes Patent Application for Radiolabeled Anti-Pd-L1 Antibodies For Immuno-Pet Imaging

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202418055061 A) filed by Regeneron Pharmaceuticals, Inc. on July 18, 2024, for Radiolabeled Anti-Pd-L1 Antibodies For Immuno-Pet Imaging.

Inventors include Kelly, Marcus; Ma, Dangshe; Olson, William Number; and Thurston, Gavin.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Radiolabeled anti-PD-L1 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of PD-L1 proteins in a patient or sample.

Disclaimer: Curated by HT Syndication....